Equity Research, Broker Reports, and media content on Spexis Ltd

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Spexis Ltd
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Spexis Ltd

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Spexis Ltd. We currently have 3 research reports from 1 professional analysts.

Date Source Announcement
07Jul22 06:30 EQS-News Spexis' CXCR4 Inhibitor Balixafortide zeigt synergistische Wirksamkeit in Kombination mit Docetaxel in einem präklinischen Modell für metastasierenden Prostatakrebs
07Jul22 06:30 EQS-News Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model
19May22 06:30 EQS-News Spexis to present at H.C. Wainwright Global Investment Conference
12May22 07:37 RNS Spexis AG - Spexis to present at BioEquity Europe 2022
12May22 06:30 EQS-News Spexis to present at BioEquity Europe 2022
27Apr22 08:20 RNS Spexis AG - Annual General Meeting
27Apr22 06:15 DGAP-AHD Spexis Annual General Meeting 2022
  • Frequency of research reports

     

  • Research reports on

    Spexis Ltd

  • Providers covering

    Spexis Ltd

Frequently asked questions